📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Mode of action studies confirm on-target engagement of lysyl-tRNA synthetase inhibitor and lead to new selection marker for Cryptosporidium (2023)

First Author: Hanna J

Attributed to: MICA: Development of new agents for the treatment of cryptosporidiosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fcimb.2023.1236814

Publication URI: http://dx.doi.org/10.3389/fcimb.2023.1236814

Type: Journal Article/Review

Parent Publication: Frontiers in Cellular and Infection Microbiology